Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson's Disease.
Jannik PrasuhnNorbert BrüggemannPublished in: Genes (2021)
Mitochondria-targeted gene therapies are a potential strategy to improve an important primary disease mechanism in Parkinsonian disorders. However, further studies are needed to address the unique design challenges for mitochondria-targeted gene therapies.